Income Research & Management's Q3 vs. Q4 2022 13F Holdings Comparison: Notable Changes in the Fund's Portfolio

Income Research & Management Q3 2022 vs. Q4 2022 13F Holdings Comparison

Investors who want to stay up-to-date with the latest investment trends look to quarterly reports filed by money managers. For example, the report recently filed by Income Research & Management offers details on the fund’s latest holdings.

In this post, we’ll analyze Income Research & Management’s Q3 2022 vs. Q4 2022 13F Holdings Comparison as represented in the provided CSV.

Overview of the Income Research & Management Fund

Before diving into the Q3 2022 vs. Q4 2022 comparison, let’s take a brief look at Income Research & Management.

This asset management firm was founded in 1993 and aims to generate high current income for its investors, with an emphasis on investment grade fixed-income securities. The firm has over $5 billion in assets under management and invests in a variety of sectors, including finance, technology, healthcare, and consumer goods.

Income Research & Management’s Q3 2022 vs. Q4 2022 13F Holdings Comparison

In Q3 2022, Income Research & Management held 20 positions worth approximately $146,644,000. By Q4 2022, the fund had retained most of its holdings, with the value of the positions increasing to approximately $154,201,000.

The biggest position in both quarters was Western Digital Corp. The fund maintained its position, holding 22.4 million shares worth $21,213,000 in both periods.

The top five holdings constituted a significant portion of the fund’s total value, accounting for approximately 38% of the total assets in Q3 2022 and 37% in Q4 2022.

Below is a detailed breakdown of the changes in holding, including the change in share amounts, change in value, and percentage change of each position.

Notable Changes in Income Research & Management Holdings

One of the energy sector’s significant players, Pioneer Natural Resources Co, was held by the fund in Q3 2022 with 4.72 million shares, worth $10.2 million. By Q4 2022, the fund had reduced its position in the company to 4.62 million shares, worth $10.7 million - a 5.4% increase in value.

Supernus Pharmaceuticals was the most minor change in the top holding list, with the fund maintaining its 7.5 million share position across both quarters. However, the value of this holding increased by 1.3%, from $7.28 million in Q3 2022 to $7.3 million in Q4 2022.

Wells Fargo, Ford Motors, and Blackstone Mortgage Trust Inc. were also held by the fund in both quarters, with minimal changes in share count and value.

Other notable changes include:

- Ares Capital Corp: The number of shares held by the fund remained consistent, with 20 million shares in both quarters. However, the position’s value increased by 3.9%, from $20.4 million in Q3 2022 to $21.2 million in Q4 2022.

- Booking Holdings Inc: Another position that held steady with 15.2 million shares in both quarters. However, its value increased by 10.9%, from $18.3 million in Q3 2022 to $20.3 million in Q4 2022.

- Teva Pharmaceutical Fin LLC: The fund did not hold any shares in Teva Pharmaceutical in Q4 2022, indicating that the fund may no longer believe that this stock has potential.

Conclusion

Income Research & Management’s Q3 2022 vs. Q4 2022 13F Holdings Comparison indicates that the fund remained relatively static in the period. However, there were notable increases in holdings such as Ares Capital Corp and Booking Holdings Inc.

The fund remains committed to holding strong positions in different sectors, with technology, finance, and consumer goods being the most notable. Seeing as the overall value of positions increased from Q3 2022 to Q4 2022, we can say that the fund is doing well and that its investors can look forward to achieving returns in the long run.